(Q44908385)

English

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

8

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

6

object named as

Mary Beth Rios

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

object named as

Francis Giles

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jorge Eduardo Cortes

1

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

7

object named as

Moshe Talpaz

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

object named as

Jianquin Shan

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Alfonso Quintas

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2396-2402

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical management of patients with chronic myeloid leukemia receiving imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Gynaecomastia in men with chronic myeloid leukaemia after imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20292

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20292

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_k4ql65oaqncadinjwjeq5hobuu

1 reference

https://api.fatcat.wiki/v0/release/k4ql65oaqncadinjwjeq5hobuu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44908385&oldid=2056701060"